FEDERAL STREET STRATEGIES, LLC

Lobbying for BRISTOL MYERS SQUIBB COMPANY · Global biopharmaceutical company.

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $30,000.00 income · posted Jan 20, 2026

Lobbying activity 1

Health Issues

Access to prescription drugs. Drug Pricing reform/implementation. Food is Medicine initiatives. Issues related to Medical Debt. Issues related to the FY2026 budget and appropriations process

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.